Not exact matches
Molecular characterization
of the cells that undergo cell fate transition upon oncogenic Pik3ca expression demonstrated a profound oncogene - induced reprogramming
of these newly formed cells and
identified gene expression signatures, characteristic
of the
different cell fate switches, which was predictive
of the
cancer cell
of origin, tumour
type and clinical outcomes in women with breast
cancers.
They
identified several distinct FGFR fusions in nine
different types of cancers, including bladder
cancer, brain
cancer and lung
cancer.
The participants had various
different types of cancer, and Hirotsu says the worms successfully
identified cancer in all nine they were exposed to — stomach, colorectal, colon, oesophageal, pancreas, bile duct, prostate, breast and lung
cancer.
Sugen has
identified 19 families
of RTKs, and abnormalities in the way they function have already been linked with
different types of cancer, as well as conditions such as diabetes.
«These two identifiable characteristics give
cancer - causing non-coding RNAs a chemical signature that makes it easy for scientists to
identify them in the early stages
of many
different types of cancer,» says Steven Jones.
Cancer biologist Todd Golub at Harvard Medical School in Boston, Massachusetts, and colleagues developed a way to identify small RNAs from more 200 cancer types and found that different types of cancer harbor different subsets of micr
Cancer biologist Todd Golub at Harvard Medical School in Boston, Massachusetts, and colleagues developed a way to
identify small RNAs from more 200
cancer types and found that different types of cancer harbor different subsets of micr
cancer types and found that
different types of cancer harbor different subsets of micr
cancer harbor
different subsets
of microRNAs.
After
identifying three
different types of resistance to a promising investigational lung
cancer drug in a phase 1 trial, a team of researchers led by Dana - Farber Cancer Institute scientists say new targeted inhibitors and combinations are urgently needed to stay ahead of tumors» constant and varied molecular shape - shi
cancer drug in a phase 1 trial, a team
of researchers led by Dana - Farber
Cancer Institute scientists say new targeted inhibitors and combinations are urgently needed to stay ahead of tumors» constant and varied molecular shape - shi
Cancer Institute scientists say new targeted inhibitors and combinations are urgently needed to stay ahead
of tumors» constant and varied molecular shape - shifting.
Although
cancer stem cells have been
identified in many
different types of cancer, it is becoming increasingly clear that the properties
of these cells may vary greatly among the
different tumor
types.